Introducing the latest benzodiazepine metabolite internal standards from Cerilliant - Norchlordiazepoxide-D5 & N-Desmethylclobazam-13C6.
|
Refer to N-101
|
N-088
|
100 µg/mL in 10% Water in Acetonitrile (v/v)
This internal standard is suited for quantification of norchlordiazepoxide in LC/MS and GC/MS benzodiazepine testing methods for urine drug testing, forensic analysis, and clinical toxicology applications. Norchlordiazepoxide is a major urinary metabolite of the benzodiazepine chlordiazepoxide, indicated for short term treatment of severe anxiety and for the management of acute alcohol withdrawal syndrome. The metabolite, also known as N-desmethylchlordiazepoxide, is pharmacologically active.
|
|
|
|
N-Desmethylclobazam-8-chloro
|
D-094
|
100 µg/mL in Acetonitrile
n-Desmethylclobazam-8-chloro isomer-13C6 is a stable-labeled structural isomer of N-Desmethylclobazam, also known as norclobazam. This standard is suitable for quantification of N-Desmethylclobazam levels in urine or other matrices by LC/MS or GC/MS for clinical toxicology, urine drug testing, or forensic analysis applications. Norclobazam is a pharmacologically active biomarker and a major metabolite of clobazam, a benzodiazepine marketed under the brand names Frisium, Urbanol, and Onfi for use as an anxiolytic and anticonvulsant.
|
|
|
Coming soon Cerilliant will offer the following benzodiazepine internal standards:
Phenazepam-D4 (P-093)
Clobazam-13C6 (C-129)